NCT03301870 - A Study to Evaluate the Irritation Potential of ATx201 in Healthy Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 4, 2017

Primary Completion Date

November 6, 2017

Study Completion Date

November 6, 2017

Conditions

Irritation Potential of Topic Agent

Interventions

DRUG

ATx201 Gel 2%

2% active gel

DRUG

ATx201 Gel 4%

4% active gel

DRUG

Positive Control

Sodium Lauryl Sulfate 0.05% (w/v), USP in sterile, distilled Water for Injection, USP

DRUG

Negative Control

Water for Injection, USP

DRUG

ATx201 Placebo

matching placebo gel

Trial Locations (1)

Bio-Kinetic Clinical Applications, LLC, Springfield